The willingness of some workers to give up their livelihoods helps explain the country’s struggle to contain the pandemic. By Sarah Maslin Nir Under the threat of losing their jobs, hundreds of thousands of New Yorkers finally got a Covid-19 vaccine. Teachers, nurses...
— Systematic vaccination is necessary but may not be sufficient for those at high risk by Daniel Teres, MD, Diana M. Stone, PhD, MPH, DVM, and Martin A. Strosberg, PhD, MPH he recent surge of COVID-19 in the southern U.S. in summer and early fall was...
For those who need boosters, the mix-and-match approach with the various vaccines seems to be safe and effective. By Ed Cara On Thursday night, Rochelle Walensky, head of the Centers for Disease Control and Prevention, gave the green light to boosters for...
— Moderna, Johnson & Johnson boosters also get thumbs up by Molly Walker The FDA authorized booster doses of Moderna and Johnson & Johnson's COVID-19 vaccines and also authorized a "mix and match" or heterologous approach to boosters for all three available...
A Houston vaccine team would like a U.S. distributor but for now focuses its efforts abroad to inoculate those in countries where COVID-19 variants surface more quickly. BY KAREN BROOKS HARPER The day before COVID-19 claimed its first Texas victim in 2020, Dr. Peter...
By Alana Wise The science is clear: Vaccines are a safe and effective way to prevent serious illness, hospitalization and death from the coronavirus, and vaccine mandates are an effective tool in promoting widespread vaccinations. Still, the battle to...
By Zeynep Tufekci Back when a viral pandemic killing millions around the world was just the plot of a scary movie, the film “Contagion” was lauded for how accurately it depicted the way such an outbreak would occur. On the science of viral contagion, it was quite...
— Researchers urge caution, but a clearer picture starts to emerge by Molly Walker A so-called "mix and match" COVID vaccine series using a different booster than the primary series was safe and produced an increase in immune response comparable to or greater than...
By Jean-Louis Montastruc, published July 11, 2021 in Fundamental & Clinical Pharmacology Abstract Several vaccines are being developed as part of the COVID-19 pandemic. The results of clinical trials for these vaccines were published with efficacy values of more...
Some poorer countries are paying more and waiting longer for the company’s vaccine than the wealthy — if they have access at all. By Rebecca Robbins Moderna, whose coronavirus vaccine appears to be the world’s best defense against Covid-19, has been...
Researchers from the University of California, Los Angeles, (USC) University of Southern California (USC), and the Cleveland Clinic conducted a meta-analysis of studies probing the risk associated with SARS-CoV-2 reinfection among those previously infected with...
Vaccine makers are betting that the mRNA technology powering two successful Covid vaccines will help curb the tragic global death toll from the flu. By Carl Zimmer As the world grapples with Covid-19, influenza isn’t getting much attention these days. But the...
Trial Site News is skeptical on Covid vaccines so we post selectively from their fact-based reports. The fact that Scandinavian countries are taking the steps described below underscores the essentially variable meaning of "follow the science" in different countries...
By Venice Servellita, et al. PREPrint ~ August 25, 2021 with Commentary from TrialSiteNews Below Abstract Associations between vaccine breakthrough cases and infection by SARS coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analyzed...
By S. V. Subramanian & Akhil Kumar Published September 30, 2021 in European Journal of Epidemiology Vaccines currently are the primary mitigation strategy to combat COVID-19 around the world. For instance, the narrative related to the ongoing surge of new cases in...